Ken Kuang: When Fluid Dynamics Meets Life-Saving Surgery
Ken Kuang, President of Torrey Hills Technologies, LLC, Partner of StockFan App, Advisor at Unpress AI, shared a post on LinkedIn:
“When Fluid Dynamics Meets Life-Saving Surgery.
Traditional medicine tells us that stubborn blood clots—the ‘white clots’ rich in fibrin—are some of the hardest obstacles to clear during a stroke.
Current suction methods often fail because these clots are too tough to aspirate, leaving surgeons with few options.
Enter the Stanford ‘Milli-spinner.’
Researchers at Stanford Medicine and Engineering have developed a tiny, high-speed rotating device that doesn’t just ‘suck’ or ‘grab’—it re-engineers the clot in real-time.
The Engineering Breakthrough:
- Mechanical Shrinking: By spinning at up to 40,000 RPM, the device creates a localized ‘rubbing’ effect.
- The 5 percent Factor: It compresses a clot to just 5 percent of its original volume, squeezing out red blood cells and condensing the fibrin into a tiny, dense bead.
- Precision Aspiration: Once condensed, the ‘shrunk’ clot is easily vacuumed out without breaking into dangerous fragments.
In trials, this ‘cotton ball’ approach jumped the success rate for tough clots from 11 percent to 90 percent on the first pass.
It’s a masterclass in how mechanical engineering and fluid dynamics can solve biological bottlenecks.
This tech is now heading toward human trials and could soon be the gold standard for treating strokes, pulmonary embolisms, and even heart attacks.
What do you think?
Is the future of surgery less about ‘cutting’ and more about high-speed mechanical manipulation at the micro-scale?”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 2, 2026, 17:27Reza Shojaei: The Invisible Crisis, Part 1: Donor Deferral in Whole Blood
-
Oct 2, 2026, 16:02Advancing Antithrombotic Stewardship to Optimise Care – American Heart Association
-
Oct 2, 2026, 15:37Pall T. Onundarson: Monitoring Warfarin Beyond Factor VII
-
Oct 2, 2026, 15:26Nicola Carter: World Thrombosis Day Highlights Gender Specific Risks and Prevention
-
Oct 2, 2026, 14:56Wolfgang Miesbach: Direct Comparison Reveals Distinct Mechanisms Among FVIIIa Mimetics
-
Oct 2, 2026, 14:47Strengthening Hemophilia Care Through Advocacy and Partnership – World Federation of Hemophilia
-
Oct 2, 2026, 14:40Maxime Dely: CAR T Cell Therapy Starts With Collection
-
Oct 2, 2026, 14:30Sadashiva Pai: The Molecular Gateway for Sphingosine-1-Phosphate Release
-
Oct 2, 2026, 14:17Aditya Rawat: Clopidogrel, CYP2C19 and the Role of Pharmacogenetics